Lisinopril and Hydrochlorothiazide Tablet
|
Generic Name |
Lisinopril and Hydrochlorothiazide |
|---|---|
|
Strength |
10 mg + 12.5 mg, 5 mg + 12.5 mg |
|
Form |
Tablet |
|
Packaging |
1 X 10 Tablets, 1 X 15 Tablets |
|
Therapeutic use |
Cardiovascular Agent, Hypertension |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Olmesartan Medoxomil and Hydrochlorothiazide Tablet | 20 mg + 12.5 mg, 40 mg + 25 mg | Cardiovascular Agent | |
| Losartan and Hydrochlorothiazide Tablet | 50 mg + 12.5 mg, 25 mg + 12.5 mg | Cardiovascular Agent | |
| Lisinopril Tablet | 2.5 mg, 5 mg, 10 mg, 20 mg | Hypertension, Cardiovascular Agent | |
| Lisinopril and Hydrochlorothiazide Tablet | 10 mg + 12.5 mg, 5 mg + 12.5 mg | Cardiovascular Agent, Hypertension | |
| Lisinopril and Amlodipine Tablet | 5 mg + 5 mg | Cardiovascular Agent, Angina, Hypertension | |
| Irbesartan and Hydrochlorothiazide Tablet | 150 mg + 12.5 mg, 300 mg + 25 mg | Cardiovascular Agent | |
| Telmisartan, Amlodipine and Hydrochlorothiazide Tablet | 40 mg + 5 mg + 12.5 mg, 80 mg + 5 mg + 12.5 mg | Cardiovascular Agent, Hypertension | |
| Telmisartan and Hydrochlorothiazide Tablet | 80 mg + 12.5 mg, 40 mg + 12.5 mg | Cardiovascular Agent, Hypertension | |
| Hydrochlorothiazide Tablet | 12.5 mg, 25 mg, 50 mg | Antihypertensive, Diuretics | |
| Ramipril and Hydrochlorothiazide Tablet | 10 mg + 12.5 mg, 2.5 mg + 12.5mg, 5 mg +12.5 mg | Cardiovascular Agent, Hypertension | |
| Amlodipine and Hydrochlorothiazide Tablet | 5mg + 12.5mg | Cardiovascular Agent | |
| Candesartan and Hydrochlorothiazide Tablets | 8 mg + 12.5 mg | Cardiovascular Agent |
Product Description For Lisinopril and Hydrochlorothiazide Tablet
products details and uses
Lisinopril and Hydrochlorothiazide Tablet Exporter, Manufacturer and Global Supplier in India
Lisinopril and Hydrochlorothiazide Tablet Exporter, as a leading we ensure the delivery of premium-quality, WHO-GMP certified formulations to international markets. Our products are widely supplied to hospitals, distributors, and pharmacies globally, backed by a robust supply chain and strict adherence to pharmaceutical quality standards. The Lisinopril and Hydrochlorothiazide Tablet is a trusted and effective combination therapy used in the treatment of hypertension (high blood pressure). It brings together two complementary agents — Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, and Hydrochlorothiazide, a thiazide diuretic — to deliver dual-action control over elevated blood pressure.
Product Overview
The Lisinopril and Hydrochlorothiazide Tablet works by targeting two major physiological pathways involved in blood pressure regulation. Lisinopril helps relax blood vessels by inhibiting the conversion of angiotensin I to angiotensin II, thereby lowering vascular resistance. Hydrochlorothiazide, on the other hand, increases urine output, reducing fluid volume and sodium levels in the bloodstream. This dual mechanism results in effective, long-lasting blood pressure reduction.
As a reliable Lisinopril and Hydrochlorothiazide Tablet Exporter, we provide this product in multiple strengths to meet diverse therapeutic requirements. Each batch undergoes rigorous quality checks to ensure potency, purity, and consistency, meeting international pharmacopeial specifications.
Uses and Indications
The Lisinopril and Hydrochlorothiazide Tablet is primarily indicated for:
-
Hypertension (Essential High Blood Pressure): To manage and maintain normal blood pressure levels, reducing the risk of stroke, heart attack, and kidney complications.
-
Adjunct Therapy: In patients who do not achieve adequate control with monotherapy.
-
Congestive Heart Failure (in some cases): Can assist in reducing symptoms and improving cardiovascular efficiency when prescribed under medical supervision.
As a reputed Lisinopril and Hydrochlorothiazide Tablet Exporter, we supply this medication to healthcare institutions that prioritize clinically proven efficacy and safety.
Dosage and Administration
Dosage should be individualized depending on patient condition and response to therapy. The tablets are typically taken once daily, with or without food, preferably at the same time each day. Adequate hydration should be maintained, and patients are advised not to skip doses. The Lisinopril and Hydrochlorothiazide Tablet should only be used under the guidance of a healthcare professional.
We, as a trusted Lisinopril and Hydrochlorothiazide Tablet Exporter, ensure detailed labeling and packaging to support proper dosage administration and compliance with international pharmaceutical regulations.
Precautions
Before initiating therapy with Lisinopril and Hydrochlorothiazide Tablets, several precautions should be observed:
-
Kidney or Liver Disorders: Dosage adjustments may be required in patients with renal or hepatic impairment.
-
Electrolyte Imbalance: Regular monitoring of serum potassium, sodium, and creatinine is recommended, as Hydrochlorothiazide can alter electrolyte levels.
-
Pregnancy and Lactation: Not recommended during pregnancy due to the potential risk to the developing fetus.
-
Allergic Reactions: Discontinue immediately if angioedema or hypersensitivity symptoms develop.
-
Hypotension: Caution should be exercised in patients with dehydration or those on diuretic therapy.
-
Diabetes: Blood glucose levels may be affected by Hydrochlorothiazide; periodic monitoring is advised.
Our company, recognized as a global Lisinopril and Hydrochlorothiazide Tablet Exporter, provides comprehensive documentation and pharmacovigilance support for safe clinical use.
Side Effects
While the Lisinopril and Hydrochlorothiazide Tablet is generally well-tolerated, some patients may experience mild to moderate side effects such as:
-
Dizziness or lightheadedness (especially on standing)
-
Headache or fatigue
-
Cough (from ACE inhibition)
-
Increased urination or electrolyte imbalance
-
Nausea, stomach upset, or dry mouth
-
Muscle cramps or weakness
Serious but rare side effects may include severe hypotension, kidney dysfunction, or allergic swelling (angioedema). Medical consultation is essential if any unusual symptoms occur.
Why Choose Us as Your Exporter and Global Supplier
As a globally recognized Lisinopril and Hydrochlorothiazide Tablet Exporter, we specialize in manufacturing and distributing high-quality cardiovascular medications that comply with stringent regulatory norms. Our facilities operate under WHO-GMP and ISO certifications, ensuring consistent quality across every batch. We offer flexible packaging options, private labeling, and third-party manufacturing services to cater to diverse market needs.
Our strong distribution network allows us to export to regulated and semi-regulated markets efficiently. By maintaining transparency, competitive pricing, and prompt delivery, we have built long-term partnerships with global healthcare providers.
For healthcare professionals and importers seeking a reliable Lisinopril and Hydrochlorothiazide Tablet Exporter, our organization stands as a trusted name dedicated to quality, innovation, and excellence in global pharmaceutical supply.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Lisinopril and Hydrochlorothiazide Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.
